BD (Becton, Dickinson and Company)
Introducing BD Rhapsody, a platform for single-cell analysis with the ability to detect rare molecules responsible for biological diversity that are often missed with whole-transcriptome profiling. Developed using unique molecular index (UMI) technology, BD Rhapsody is a complete system of reagents, instruments, and software for targeted gene-expression analysis of tens of thousands of individual cells. The product was previously in limited commercial release under the name Resolve. The company will offer both application-specific targeted panels and enable customers to design their own custom, targeted panels.